Stay updated on Selinexor Combinations in Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Combinations in Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Selinexor Combinations in Refractory Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe record history now shows a new version entry (Revision: v3.4.2) added and the previous version (v3.4.1) removed, indicating a minor update to the history log. These entries do not alter study data or core content.SummaryDifference0.1%

- Check15 days agoChange DetectedA new Revision: v3.4.1 was added to the history, and the government funding status notice as well as the prior Revision: v3.4.0 entry were removed.SummaryDifference0.7%

- Check22 days agoChange DetectedNew sections such as Contacts/Locations, Oversight, and Study Status were added to the record history, and a government funding notice was introduced. A deletion was recorded on 2025-10-03.SummaryDifference1%

- Check29 days agoChange DetectedThe update adds a glossary option and a legend that explains the color-coding of changes (green for additions, red for deletions) in the history view, and updates version labels to v3.4.0 while removing the older No FEAR Act data and Revision: v3.3.4 notes. This is a UI/documentation change rather than a modification to study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check36 days agoChange DetectedA new revision entry (v3.3.4) appears, replacing the prior (v3.3.3); no study content or status changes are visible in this update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.3.3 was added to the page footer and the HHS Vulnerability Disclosure link was removed. This is a minor site maintenance update that does not affect the study record content.SummaryDifference0.2%

Stay in the know with updates to Selinexor Combinations in Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Combinations in Refractory Multiple Myeloma Clinical Trial page.